Hutch News

Hutch News

Stories tagged 'hutchinson institute for cancer outcomes research'

Fred Hutch and Microsoft partner for better cancer care delivery

Project to flag treatment-related symptoms early is revealed at Seattle conference

May 4, 2018 | By Sabin Russell / Fred Hutch News Service

A Fred Hutch-Microsoft partnership to develop and pilot test technology to help cancer patients was revealed at the fifth annual Value in Cancer Care Summit, held Thursday in Seattle.

View story >


Hutch health economics group releases its first public report

Community Cancer Care Report on quality and cost is the product of five years of stakeholder collaboration

May 1, 2018 | By Diane Mapes / Fred Hutch News Service

Fred Hutch’s HICOR releases its Community Cancer Care Report, the first public report linking quality and cost measures for cancer clinics.

View story >


President's Cancer Panel addresses cost of cancer drugs

Fred Hutch leaders helped shape recommendations that put patients first, promoting value, affordability, innovation

March 12, 2018 | By Sabin Russell / Fred Hutch News Service

The President's Cancer Panel, an independent advisory group, called for “urgent action” to address rapidly rising prices for cancer drugs and the burden cancer patients and their families face because of the high cost of cancer care.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

Dec. 14, 2017

Fred Hutchinson Cancer Research Center has announced awards totaling $1 million to nine of its scientists through the Evergreen Fund, a unique grant program that supports homegrown research projects deemed attractive to potential commercial partners. This is the second year of Evergreen Fund awards. This is the second year of Evergreen Fund awards. The Hutch’s Business Development & Strategy office created the program in 2016 in an effort to encourage scientists to pursue creative ideas with commercial appeal. The goal is to speed research from the bench to the bedside while generating income from patent rights and partnerships with the business sector.

View story >


Big study finds no rise in death risk among women who took hormone therapy

A new twist to menopausal hormone replacement dilemma

Sept. 12, 2017 | Sabin Russell / Fred Hutch News Service

New follow-up research to a landmark study on menopausal hormone replacement therapy has found that women assigned to those drugs on the study had no higher risk of death than women who took a placebo.

View story >


New guidelines take aim at chemo-related nausea

Cancer patients ‘should not be vomiting with chemo anymore.’ Can someone please tell Hollywood?

Aug. 24, 2017 | By Diane Mapes / Fred Hutch News Service

Nausea and vomiting is a weird thing to … uh … bring up, writes cancer survivor Diane Mapes. But a lot of people don't seem to realize these common chemo side effects are now well controlled with anti-nausea drugs. New guidelines, co-written by Fred Hutch's Dr. Gary Lyman, break it all down.

View story >



(RSS feeds are best viewed in browsers other than Chrome)

Editor's Picks

GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.